Ubie
Empowering personalized healthcare through advanced AI-driven symptom analysis and streamlined clinical documentation tools tailored for medical professionals.
Empowering personalized healthcare through advanced AI-driven symptom analysis and streamlined clinical documentation tools tailored for medical professionals.
Ubie is an innovative healthcare startup that focuses on leveraging advanced AI technology to provide personalized healthcare solutions. The company offers an AI symptom checker software, allowing patients to receive tailored evaluation reports. Additionally, Ubie provides AI-powered healthcare tools such as "Ubie for Hospital" or AI Monshin, a SaaS product designed to assist medical institutions in creating clinical records with input from specialists. Founded on May 1, 2017, in Nihonbashi Muromachi, Tokyo by Kota Kubo and Dr. Yoshinori Abe, Ubie operates within the AI, Health Care, SaaS, and Machine Learning industries. Ubie recently secured a significant ¥3.50B Debt Financing investment on April 12, 2024, with contributions from notable investors including Sumitomo Mitsui Trust Bank, Mizuho Bank, Mitsubishi UFJ, and JA Mitsui Leasing. The company's commitment to harnessing AI for personalized healthcare and its successful fundraising efforts make it an intriguing prospect for potential venture capital investment.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Debt Financing | ¥3.50B | 4 |
|
12 Apr 2024 |
| Debt Financing | $1.90M | 3 |
|
08 Dec 2022 |
| Series C | $17.10M | 4 |
|
08 Dec 2022 |
| Series C | $26.20M | 4 |
|
22 Aug 2022 |
| Series B | ¥1.10B | - | 08 Jan 2021 |
No recent news or press coverage available for Ubie.
We care about your data, and we'd love to use cookies make your experience better.
